VF
CRSP icon

Virtu Financial’s CRISPR Therapeutics CRSP Stock Holding History

Virtu Financial’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$551K Sell
11,590
-4,854
-30% -$256K 0.02% 537
2025
Q4 		$862K Buy
+16,444
New +$985K 0.03% 406
2025
Q2 		– Sell
-14,014
Closed -$477K – 1562
2025
Q1 		$477K Buy
+14,014
New +$594K 0.03% 507
2024
Q4 		– Sell
-7,734
Closed -$363K – 1626
2024
Q3 		$363K Sell
7,734
-2,211
-22% -$112K 0.02% 557
2024
Q2 		$537K Sell
9,945
-53,797
-84% -$3.11M 0.04% 426
2024
Q1 		$4.34M Buy
63,742
+32,880
+107% +$2.35M 0.33% 44
2023
Q4 		$1.93M Buy
30,862
+17,186
+126% +$950K 0.15% 100
2023
Q3 		$621K Sell
13,676
-12,907
-49% -$667K 0.06% 284
2023
Q2 		$1.49M Buy
+26,583
New +$1.51M 0.11% 140
2022
Q4 		– Sell
-13,777
Closed -$900K – 1705
2022
Q3 		$900K Sell
13,777
-42,534
-76% -$3.08M 0.08% 219
2022
Q2 		$3.42M Buy
56,311
+33,910
+151% +$1.99M 0.29% 52
2022
Q1 		$1.41M Buy
22,401
+11,525
+106% +$724K 0.1% 156
2021
Q4 		$824K Buy
+10,876
New +$950K 0.08% 224
2021
Q2 		– Sell
-21,000
Closed -$2.56M – 1596
2021
Q1 		$2.56M Buy
+21,000
New +$3.17M 0.18% 72
2018
Q2 		– Sell
-5,352
Closed -$245K – 2042
2018
Q1 		$245K Buy
+5,352
New +$221K 0.01% 1206

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GP
GSK plc London $599M AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Virtu Financial's CRSP Position: Q1 2026 in Review

Virtu Financial reduced its CRISPR Therapeutics (CRSP) stake by 30% in Q1 2026, selling an estimated $256K and leaving 11,590 shares worth $551K. The position accounts for 0.02% of the portfolio, ranked #537.

Virtu Financial first reported a position in CRSP in Q1 2018 and has held it in 15 quarters since. The position peaked at $4.34M in Q1 2024. 488 funds tracked by Wall St. Rank hold CRSP as of Q1 2026.

  • Virtu Financial held 11,590 shares of CRISPR Therapeutics worth $551K as of Q1 2026.
  • Virtu Financial sold 4,854 CRISPR Therapeutics shares in Q1 2026, an estimated $256K.
  • CRISPR Therapeutics made up 0.02% of Virtu Financial's portfolio in Q1 2026, its #537 holding.
  • Virtu Financial first reported a position in CRISPR Therapeutics in Q1 2018 and has held it in 15 quarters since.
  • Virtu Financial's CRISPR Therapeutics position peaked at $4.34M in Q1 2024.
  • 488 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.